These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 21047207)
21. [Therapeutic monitoring of immunosuppressive drugs: interest of calcineurin activity assessment in liver transplantation]. Blanchet B Ann Pharm Fr; 2008 Mar; 66(2):96-101. PubMed ID: 18570908 [TBL] [Abstract][Full Text] [Related]
22. Sirolimus monotherapy effectiveness in liver transplant recipients with renal dysfunction due to calcineurin inhibitors. Di Benedetto F; Di Sandro S; De Ruvo N; Spaggiari M; Montalti R; Ballarin R; Cappelli G; Gerunda GE J Clin Gastroenterol; 2009 Mar; 43(3):280-6. PubMed ID: 19057397 [TBL] [Abstract][Full Text] [Related]
23. Calcineurin inhibitors: 40 years later, can't live without .. Azzi JR; Sayegh MH; Mallat SG J Immunol; 2013 Dec; 191(12):5785-91. PubMed ID: 24319282 [TBL] [Abstract][Full Text] [Related]
24. [Controversies about the use of calcineurin inhibitors in pediatric patients]. Dello Strologo L G Ital Nefrol; 2008; 25(3):317-24. PubMed ID: 18473303 [TBL] [Abstract][Full Text] [Related]
25. Differential expression of tissue factor (TF) in calcineurin inhibitor-induced nephrotoxicity and rejection--implications for development of a possible diagnostic marker. Osterholm C; Veress B; Simanaitis M; Hedner U; Ekberg H Transpl Immunol; 2005 Dec; 15(2):165-72. PubMed ID: 16412961 [TBL] [Abstract][Full Text] [Related]
26. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function. Watson CJ; Gimson AE; Alexander GJ; Allison ME; Gibbs P; Smith JC; Palmer CR; Bradley JA Liver Transpl; 2007 Dec; 13(12):1694-702. PubMed ID: 18044728 [TBL] [Abstract][Full Text] [Related]